X0708 D LIVE 0001631487 CollPlant Biotechnologies Ltd 4 OPPENHEIMER, WEIZMANN SCIENCE PARK REHOVOT L3 ISRAEL 7670104 +972 73 232 5600 ISRAEL None CollPlant Holdings Ltd. CollPlant Biotechnologies Ltd. Corporation true Yehiel Tal COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Director Chief Executive Officer and Interim Chairman of the Board of Directors Eran Rotem COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Deputy Chief Executive Officer and Chief Financial Officer Oren Fahimipoor COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Vice President, Operations Philippe Bensimon COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Vice President, Regulatory Affairs and Quality Assurance Jasmine Seror COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Vice President, Product Development Bowman Bagley COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Vice President, Commercial North America Bar Abelis COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Executive Officer Vice President, Legal Abraham Havron COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Director Elan Penn COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Director Joseph Zarzewsky COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Director Hugh Evans COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Director Alisa Lask COLLPLANT BIOTECHNOLOGIES LTD 4 Oppenheimer, Weizmann Science Park Rehovot L3 ISRAEL 7670104 Director Other Health Care Decline to Disclose 06b false 2026-07-06 false true true true true Series A warrants and series B warrants to purchase ordinary shares, including underlying ordinary shares upon exercise. false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 Park Avenue 3rd Floor New York NY NEW YORK 10022 FL FLORIDA NY NEW YORK TX TEXAS true 10400000 10400000 0 Including the exercise price of ordinary shares underlying such warrants at an exercise price of $0.34. The total offering amount excludes placement agent warrants (see Item 15). false 5 272000 true 0 Includes placement and management fees, $35,000 non-accountable expense allowance, reimbursement of up to $50,000 legal fees and $15,950 clearing expenses, and warrants exercisable upon shareholder approval for 458,824 ordinary shares at $0.425/share. 0 true The Company intends to use net proceeds for general corporate purposes, including working capital, R&D programs, and evaluating strategic business combinations and other strategic transactions, the amount of which cannot currently be estimated. false CollPlant Biotechnologies Ltd /s/ Eran Rotem Eran Rotem Deputy Chief Executive Officer and Chief Financial Officer 2026-07-20